| Patents for C07C 405 - Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins (3,702) |
|---|
| 10/22/2003 | EP1083168B1 Prostaglandin derivative |
| 10/22/2003 | CN1450899A Bile secretion promoting composition |
| 10/14/2003 | US6632958 Process for producing a purified prostaglandin derivative |
| 10/02/2003 | WO2003080552A2 Cyclopentenone derivatives, their preparation and use in medecime |
| 10/02/2003 | US20030187071 Process and intermediates to prepare latanoprost |
| 10/02/2003 | US20030186939 Such as (5Z,11a,13E)-11,16-dihydroxy-9-oxo-17,17-propanoprosta-5,13-dienoic acid methylester; for autoimmune diseases, organ transplantation, asthma, abnormal bone formation, neuron cell death, liver disorders, and glaucoma |
| 10/01/2003 | EP1348437A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 09/25/2003 | US20030181493 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 09/12/2003 | WO2003074481A2 Preparation of prostamides |
| 09/12/2003 | WO2003037857A3 Improvements relating to prostaglandins and their analogues |
| 09/04/2003 | US20030166729 Use of prostaglandin derivatives of PGA, PGB, PGD, PGE and PGF, in which omega chain has been modified with common feature of containing a ring structure, for treatment of glaucoma or ocular hypertension |
| 09/02/2003 | US6613932 Prostaglandin derivatives |
| 08/19/2003 | CA2133830C Micromechanical thermoelectric sensor element |
| 08/19/2003 | CA2043077C Prostaglandin analogues for use in medicine |
| 08/07/2003 | US20030149294 Process for the preparation of latanoprost |
| 08/05/2003 | US6602900 F-type prostaglandins as ocular hypotensives |
| 07/23/2003 | EP1025083B1 Process for stereoselective synthesis of prostacyclin derivatives |
| 07/10/2003 | US20030130352 Such as 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E for treatment of cystic fibrosis |
| 07/01/2003 | US6586468 ω-substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient |
| 07/01/2003 | US6586463 Prostaglandin F analogs for treating bone disorders and glaucoma; selective for specific receptors |
| 06/19/2003 | US20030114528 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 06/18/2003 | EP1318979A1 Cyclopentane derivatives as therapeutic agents |
| 06/10/2003 | US6576785 ω-cycloalkyl-prostaglandin E2 derivatives |
| 06/10/2003 | US6576663 6-Keto prostaglandin F1α and analogs for treating dry eye |
| 05/28/2003 | CN1420865A Ocular hypotensive lipids |
| 05/22/2003 | US20030097023 For prophylaxis and therapy of immunological diseases, asthma, abnormal bone formation, neuronal cell death, lung failure, liver damage, acute hepatitis, nephritis, renal insufficiency, hypertension, myocardiac ischemia |
| 05/21/2003 | EP1169325B1 Novel intermediate for the synthesis of prostaglandins |
| 05/21/2003 | CN1419437A Compositions and method for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 05/14/2003 | CN1108289C Difluoroprostaglundin derivatives and their use |
| 05/08/2003 | WO2003037857A2 Improvements relating to prostaglandins and their analogues |
| 05/08/2003 | WO2003037353A1 Improvements relating to prostaglandins and their analogues |
| 04/17/2003 | WO2003030912A1 Prostaglandin analogs as chloride channel opener |
| 04/16/2003 | EP1008588B1 11,15-o-dialkylprostaglandin e derivatives, process for producing the same, and drugs containing the same as the active ingredient |
| 03/27/2003 | US20030060506 Bile secretion promoting composition |
| 03/20/2003 | WO2002096898A3 Process for the preparation of prostaglandins and analogues thereof |
| 03/18/2003 | CA2109110C Prostaglandin e1 analogues |
| 03/11/2003 | US6531614 Converting lactone to monosilyloxy carboxaldehyde for treatment of glaucoma and ocular hypertension |
| 03/11/2003 | US6531485 Prostaglandin agonists |
| 03/06/2003 | US20030045571 Process and intermediates to prepare latanoprost |
| 03/04/2003 | US6528688 Cobalt-mediated cyclization, in which a complex is formed with the alkynyl group of the starting compound, which decomposes upon heating to form a tricyclic structure |
| 02/27/2003 | WO2002089813A3 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 02/06/2003 | WO2003009872A1 Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient |
| 02/06/2003 | US20030027846 Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/30/2003 | WO2003008368A1 Process and intermediates to prepare latanoprost |
| 01/30/2003 | US20030022933 Administering to the patient a cathartic- inducing effective amount of halogenated bioactive lipid |
| 01/30/2003 | CA2453631A1 Process and intermediates to prepare latanoprost |
| 01/28/2003 | US6512139 Oxidation inhibitors in prostane derivatives |
| 01/09/2003 | US20030008895 Prostaglandin agonists |
| 01/08/2003 | CN1390199A Prostaglandin derivatives |
| 01/02/2003 | US20030004368 For production of etiproston and other prostaglandin F2A derivatives for treatment of glaucoma and ocular hypertension |
| 01/02/2003 | EP1267883A2 Bile secretion promoting composition containing a prostaglandin |
| 01/02/2003 | EP1267803A2 Compositions and methods for treating hair loss using c 16? - c 20? aromatic tetrahydro prostaglandins |
| 12/26/2002 | US20020198249 Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 12/19/2002 | WO2002100388A2 Cyclopentane heptan (ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 12/19/2002 | CA2450220A1 Cyclopentane heptan (ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 12/11/2002 | CN1384819A 前列腺素e类似物 E prostaglandin analogs |
| 12/10/2002 | US6492417 11-deoxy-16-fluoro-PGF2α analogs as FP receptor antagonists |
| 12/05/2002 | WO2002096898A2 Process for the preparation of prostaglandins and analogues thereof |
| 12/05/2002 | WO2002096868A2 Preparation of 17-phenyl- 18, 19, 20- trinor-pgf2a and its derivatives |
| 12/05/2002 | CA2448631A1 Preparation of 17-phenyl- 18, 19, 20- trinor-pgf2.alpha. and its derivatives |
| 12/05/2002 | CA2448088A1 Process for the preparation of prostaglandins and analogues thereof |
| 12/04/2002 | EP1261598A1 Internal 1,15-lactones of fluprostenol and related prostaglandin f2alpha analogs and their use in the treatment of glaucoma and intraocular hypertension |
| 11/28/2002 | WO2002094274A1 Cathartic composition |
| 11/27/2002 | CN1382121A C16 unsaturated FP-selective prostaglandins analogs |
| 11/21/2002 | US20020173672 Process for stereoselective synthesis of prostacyclin derivatives |
| 11/21/2002 | US20020173525 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 11/19/2002 | US6482990 Prostaglandin E analogues |
| 11/14/2002 | WO2002090324A1 Process for preparing prostaglandin derivatives and stereospecific starting material thereof |
| 11/14/2002 | WO2002089813A2 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 11/06/2002 | EP1254112A2 Ocular hypotensive lipids |
| 11/06/2002 | EP1012137B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 11/05/2002 | US6476064 Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents |
| 10/30/2002 | EP1252138A2 A new process for the preparation of latanoprost |
| 10/22/2002 | US6469062 Use of 15-keto-prostaglandins in promoting bile secretion |
| 10/17/2002 | WO2001057015A9 INTERNAL 1,15-LACTONES OF FLUPROSTENOL AND RELATED PROSTAGLANDIN F2α ANALOGS AND THEIR USE IN THE TREATMENT OF GLAUCOMA AND INTRAOCULAR HYPERTENSION |
| 10/17/2002 | US20020151587 15-fluoro prostaglandins as acular hypotensives |
| 10/09/2002 | CN1373752A Prostaglandin derivs. |
| 10/08/2002 | US6462081 5-thia-ω-substituted phenyl-prostaglandin E derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 10/03/2002 | US20020143054 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 10/02/2002 | EP1245562A1 5-THIA-$g(v)-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 09/26/2002 | US20020137793 Stimulate mucin production in human conjuctival epithelium by applying topically |
| 09/24/2002 | US6455584 Growth inhibition of vascular smooth muscle; prevention or therapy of the restenosis after ptca. |
| 09/17/2002 | US6451859 C16 unsaturated FP-selective prostaglandins analogs |
| 09/11/2002 | CN1368959A Prostaglandin derivatives |
| 09/03/2002 | US6444840 Bone disorders; vision defects |
| 08/27/2002 | US6441245 Process for stereoselective synthesis of prostacyclin derivatives |
| 08/20/2002 | US6437152 Intermediate for the synthesis of prostaglandins |
| 08/20/2002 | CA2062653C Promotion of wound-healing with 15-keto-prostaglandin compounds |
| 08/15/2002 | US20020111499 Novel intermediate for the synthesis of prostaglandins |
| 08/15/2002 | US20020111381 Vision disorders; topical applying |
| 08/08/2002 | US20020107414 Method of prostaglandin synthesis |
| 08/06/2002 | US6429226 Prostaglandin derivatives with phenyl ring in omega chain; topical application |
| 07/24/2002 | EP1225168A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 07/24/2002 | EP1224935A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 07/24/2002 | EP1224934A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 07/24/2002 | EP0930296B1 Fluorinated prostaglandin derivatives and medicines |
| 07/16/2002 | US6420422 Ocular hypotensive agents |
| 07/11/2002 | WO2001076593A3 Bile secretion promoting composition a 15-keto prostaglandin |
| 07/09/2002 | US6417230 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 07/09/2002 | US6417228 Treatment of glaucoma and hypotensive agents |